Marizyme, Inc.
MRZM · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $4,547 | $21,585 | $63,794 | $65,935 |
| - Cash | $148 | $511 | $4,072 | $2,903 |
| + Debt | $20,758 | $5,369 | $1,782 | $1,318 |
| Enterprise Value | $25,156 | $26,444 | $61,503 | $64,350 |
| Revenue | $646 | $233 | $210 | $197 |
| % Growth | 176.6% | 11% | 6.7% | – |
| Gross Profit | $239 | $179 | $130 | $139 |
| % Margin | 37% | 76.7% | 61.8% | 70.4% |
| EBITDA | -$55,444 | -$34,535 | -$10,828 | -$5,208 |
| % Margin | -8,585.2% | -14,791.2% | -5,149.4% | -2,641.9% |
| Net Income | -$69,539 | -$38,166 | -$10,998 | -$5,845 |
| % Margin | -10,767.8% | -16,346.2% | -5,230.2% | -2,965% |
| EPS Diluted | -1.53 | -0.94 | -0.31 | -0.22 |
| % Growth | -62.8% | -203.2% | -40.9% | – |
| Operating Cash Flow | -$4,685 | -$10,852 | -$5,787 | -$3,224 |
| Capital Expenditures | $0 | $0 | $0 | -$149 |
| Free Cash Flow | -$4,685 | -$10,852 | -$5,787 | -$3,372 |